1. Home
  2. MARPS vs BGLC Comparison

MARPS vs BGLC Comparison

Compare MARPS & BGLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Marine Petroleum Trust Units of Beneficial Interest

MARPS

Marine Petroleum Trust Units of Beneficial Interest

HOLD

Current Price

$4.22

Market Cap

9.1M

Sector

Energy

ML Signal

HOLD

Logo BioNexus Gene Lab Corp

BGLC

BioNexus Gene Lab Corp

HOLD

Current Price

$3.95

Market Cap

10.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MARPS
BGLC
Founded
1956
2017
Country
United States
Malaysia
Employees
N/A
N/A
Industry
Oil & Gas Production
Medical Specialities
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.1M
10.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
MARPS
BGLC
Price
$4.22
$3.95
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
22.8K
58.7K
Earning Date
02-13-2026
11-14-2025
Dividend Yield
8.66%
N/A
EPS Growth
N/A
N/A
EPS
0.31
N/A
Revenue
$965,040.00
$9,465,006.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$13.26
N/A
Revenue Growth
N/A
2.21
52 Week Low
$3.34
$2.01
52 Week High
$7.90
$15.60

Technical Indicators

Market Signals
Indicator
MARPS
BGLC
Relative Strength Index (RSI) 43.90 32.22
Support Level $4.11 $3.98
Resistance Level $4.44 $4.04
Average True Range (ATR) 0.28 0.13
MACD -0.02 0.00
Stochastic Oscillator 5.18 2.52

Price Performance

Historical Comparison
MARPS
BGLC

About MARPS Marine Petroleum Trust Units of Beneficial Interest

Marine Petroleum Trust is a U.S based royalty trust. It provides administration and liquidation of rights to payments from oil and natural gas leases in the Gulf of Mexico. The Trust's subsidiary holds title to interests in properties which are situated offshore of Louisiana. The revenues of the trust are derived from the oil and natural gas production activities of third parties.

About BGLC BioNexus Gene Lab Corp

BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.

Share on Social Networks: